Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adrenocortical steroidogenic enzymes are a group of specialized proteins, primarily belonging to the cytochrome P450 (CYP) superfamily and hydroxysteroid dehydrogenase (HSD) families, located within the distinct zones of the adrenal cortex (Source: NIH, 2021). These enzymes, including CYP11A1, CYP17A1, CYP21A2, CYP11B1, and CYP11B2, catalyze the sequential conversion of cholesterol into essential steroid hormones such as cortisol, aldosterone, and dehydroepiandrosterone (DHEA) (Source: Wikipedia, 2024). They play a critical role in regulating glucose metabolism, blood pressure, and secondary sexual characteristics. Dysregulation of these enzymes, whether through genetic mutations or autonomous tumors, leads to severe endocrine disorders like Cushing's syndrome, primary aldosteronism, and congenital adrenal hyperplasia (Source: StatPearls, 2023). Pharmacological inhibitors like ketoconazole, metyrapone, and osilodrostat target these enzymes to suppress hormone overproduction, though their use requires careful monitoring to prevent adrenal insufficiency and manage potential hepatotoxicity or electrolyte imbalances (Source: Medscape, 2024).
Competitive or non-competitive inhibition of specific enzymatic steps in the steroid biosynthetic pathway, such as 11-beta-hydroxylation, 17-alpha-hydroxylation, or cholesterol side-chain cleavage, to reduce the synthesis of active corticosteroids.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adrenocortical steroidogenic enzymes.